Yüklüyor......

Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III–IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common potentially life-threatening inherited kidney diseases. It is the fourth most common cause of end-stage renal disease requiring renal replacement therapy. There are few management options for controlling disea...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Trials
Asıl Yazarlar: Gan, Jing, Wu, Yansheng, Gong, Xuezhong, Ma, Yiyi, Yu, Shengqiang, Gao, Jiandong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6686499/
https://ncbi.nlm.nih.gov/pubmed/31391092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3563-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!